The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants

Journal of Neuroendocrinology

Volumn 11, Issue 7, 1999, Pages 521-528

  Korbonits, M ^a   Little, J A ^a   Forsling, M L ^b   Tringali, G ^d   Costa, A ^d   Navarra, P ^c   Trainer, P J ^a   Grossman, A B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c CATHOLIC UNIVERSITY   (Italy)

^d NONE

Author keywords

Arginine vasopressin; Corticotrophin releasing hormone; Growth hormone secratagogues; Growth hormone releasing hormone; Growth hormone releasing peptides; Hypothalamus; Rat; Somatostatin

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; GHRP 8; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; NEUROPEPTIDE Y; PEPTIDE; POTASSIUM; SOMATOSTATIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSTATIN RELEASE;

ANIMALS; ARGININE; ARGININE VASOPRESSIN; CORTICOTROPIN-RELEASING HORMONE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; SOMATOSTATIN;

EID: 0033038731     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1999.00353.x     Document Type: Article

References (58)

1. Howard AD, Feighner SD, Cully DF, Liberator PA, Arena JP, Rosenblum CI, Hamelin MJ, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu K, Kulju McKee K, Pong S, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-977.
2. Bowers CY, Sartor AO, Reynolds GA, Badger TM. On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991; 128: 2027-2035.
3. Dickson SL, Leng G, Robinson ICAF. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience 1993; 53: 303-306.
4. Clark RG, Carlsson L, Trojnar J, Robinson ICAF. The effect of growth hormone-releasing peptide and growth hormone-releasing factor on conscious and anaesthetized rats. J Neuroendocrinol 1989; 1: 249-255.
5. Hayashi S, Kaji H, Ohashi S, Abe H, Chihara K. Effect of intravenous administration of growth hormone-releasing peptide on plasma growth hormone in patients with short stature. Clin Paediatr Endocrinol 1993; 2 (Suppl): 69-74.
6. Pombo M, Barreiro J, Penalva A, Peino R, Dieguez C, Casanueva FF. Absence of growth-hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary-stalk transection. J Clin Endocrinol Metab 1995; 80: 3180-3184.
7. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. Blocked growth hormone-releasing peptide (GHRP-6)-induced growth hormone secretion and absence of the synergic action of GHRP-6 plus growth hormone-releasing hormone in patients with hypothalamopituitary disconnection-evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 1995; 80: 942-947.
8. Dickson SL, Leng G, Dyball REJ, Smith RG. Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinol 1995; 61: 36-43.
9. Guillaume V, Magnan E, Cataldi M, Dutuor A, Sauze N, Conte-Delvox B, Oliver C, Lenaerts V, Deghenghi R. GH-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 1994; 135: 1073-1076.
10. Fletcher TP, Thomas GB, Clarke IJ. Growth hormone-releasing hormone and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6. Dom Animal Endocrinol 1996; 13: 251-258.
11. 2 on GH release in conscious, freely moving male rats. Neuroendocrinol 1996; 63: 198-206.
12. Fairhall KM, Mynett A, Robinson ICAF. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth-hormone release are inhibited by central somatostatin action. J Endocrinol 1995; 144: 555-560.
13. Bowers CY, Momany FA. Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic heptapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984; 114: 1537-1545.
14. Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, and oral administration in man. J Clin Endocrinol Metab 1994; 78: 693-698.
15. Gertz BJ, Barrett JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibold JR, Schneider SH. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab 1993; 77: 1393-1397.
16. Korbonits M, Trainer PJ, Besser GM. The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin Endocrinol (Oxf) 1995; 43: 365-371.
17. Thomas GB, Fairhall KM, Robinson ICAF. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 1997; 138: 1585-1591.
18. Korbonits M, Grossman AB. Growth hormone-releasing peptide and its analogues; novel stimuli to growth hormone release. Trends Endocrinol Metab 1995; 6: 43-49.
19. Massoud AF, Hindmarsh PC, Brook CGD. Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Clin Endocrinol (Oxf) 1997; 47: 537-547.
20. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosin 3′,5′-monophosphate accumulation in rat pituitary cell culture. Endocrinology 1989; 124: 2791-2798.
21. Cheng K, Chan WWS, Butler B, Wei L, Smith RG. A novel non-peptidyl growth hormone secretagogue. Horm Res 1993; 40: 109-115.
22. Dickson SL, Luckman SM. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997; 138: 771-777.
23. Rettori V, Milenkovic L, Aguila MC, McCann SM. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 1990; 126: 2296-2301.
24. Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 1996; 137: 3-12.
25. Suzuki N, Okada K, Minami S, Wakabayashi I. Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both. Y 1996; 1:- and Y2-receptor subtypes and abolished after anterolateral deafferentation of the medial basal hypothalamus. Regul Pept; 65: 145-151.
26. Liposits Z, Sievers L, Paull WK. Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. Histochemistry 1988; 88: 227-234.
27. Tsagarakis S, Rees LH, Besser GM, Grossman AB. Neuropeptide-Y stimulates corticotrophin-releasing factor-41 release from the rat hypothalamus In Vitro Brain Res 1989; 502: 167-170.
28. Iwai C, Ochiai H, Nakai Y. Electron-microscopic immunochemistry of neuropeptide Y immunoreactive innervation of vasopressin neurons in the paraventricular nucleus of the rat hypothalamus. Acta Anal 1989; 136: 279-284.
29. Willoughby JO, Blessing WW. Neuropeptide Y injected into the supraoptic nucleus causes secretion of vasopressin in the unanesthetized rat. Neurosci Lett 1987; 75: 17-22.
30. Larsen PJ, Jukes KE, Chowdrey HS, Lightman SL, Jessop DS. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland. Endocrinology 1994; 134: 1635-1639.
31. Rudolf K. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP 3226. Eur J Pharmacol 1994; 272: R11-R13.
32. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz HL. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981; 212: 1279-1281.
33. Berelowitz M, Firestone S, Frohman LA. Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on somatostatin distribution. Endocrinology 1981; 109: 714-719.
34. Berelowitz M, Dudlak D, Frohman LA. Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones. J Clin Invest 1982; 69: 1293-1301.
35. Lengyel A-M, Grossman AB, Niewenhuyzen-Kruseman AC, Ackland J, Rees LH, Besser GM. Glucose modulation of somatostatin and LHRH release from rat hypothalamic fragments in vitro. Neuroendocrinol 1984; 39: 31-38.
36. Aguila MC, McCann SM. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism. Endocrinology 1985; 117: 762-765.
37. Lengyel A-M, Grossman AB, Bouloux G, Rees LH, Besser GM. Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro. J Endocrinol 1985; 106: 317-322.
38. Shibasaki T, Yamauchi N, Hotta M, Masuda A, Imaki T, Demura H, Ling N, Shizume K. In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-1. Regul Pept 1986; 15: 47-53.
39. Tsagarakis S, Ge F, Rees LH, Besser GM, Grossman AB. Stimulation of alpha-adrenoceptors facilitates the release of growth hormone-releasing hormone from rat hypothalamus In Vitro J Neuroendocrinol 1989; 1: 129-133.
40. Honegger J, Spagnoli A, D'Urso R, Navarra P, Tsagarakis S, Besser GM, Grossman AB. Interleukin-1β modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology 1991; 129: 1275-1282.
41. Aguila MC, Boggaram V, McCann SM. Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Brain Res 1993; 625: 213-218.
42. Mancuso C, Tringali G, Grossman AB, Preziosi P, Navarra P. The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin 1β from the rat hypothalamus in vitro: evidence for the involvement of the different signaling pathways. Endocrinology 1998; 139: 1031-1039.
43. Korbonits M, Little JA, Camacho-Hübner C, Trainer PJ, Besser GM, Grossman AB. Insulin-like growth factor-I and -II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro. Growth Regul 1996; 6: 110-120.
44. Cunnah D, Jessop DS, Besser GM, Rees LH. Measurement of circulating corticotrophin-releasing factor in man. J Endocrinol 1987; 113: 123-131.
45. Forsling ML. Measurement of vasopressin in body fluids. In: Baylis PH, Padfield PL, eds. Posterior Pituitary, New York: Marcel Dekker Inc, 1985: 161-192.
46. Cugini CD, Millard WJ, Leidy JW Jr Signal transduction systems in growth hormone-releasing hormone and somatostatin release from perifused rat hypothalamic fragments. Endocrinology 1991; 129: 1355-1362.
47. Smith RG, Van der Ploeg LHT, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ Jr, Fisher MH, Nargund RP, Patchett AA. Peptidomimetic regulation of growth hormone secretion. Endocrine Rev 1997; 18:621-645.
48. Huhman KL, Babagbemi TO, Albers HE. Bicucullin blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters. Brain Res 1998; 675: 333-336.
49. Hao EH, Malozowski S, Ren SG, Marin G, Southers J, Merriam GR. A comparison of the effect of GH-releasing hormone (GHRH) and GH-releasing peptide (GHRP) on GH and somatostatin (SRIF) release. In: Seventieth Annual Meeting of the Endocrine Society, New Orleans, LA, 1988. 411.
50. Harfstrand A, Eneroth P, Agnati L, Fuxe K. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to the hypothalamic catecholamines. Regul Pept 1987; 17: 169-179.
51. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD. Expression of growth hormone secretagogue receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 1998; 139: 4420-4423.
52. Guan X, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LHT, Howard AD. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 1997; 48: 23-29.
53. Bennett PA, Thomas GB, Howard AD, Feighner SD, Van der Ploeg LHT, Smith RG, Robinson ICAF. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 1997; 138: 4552-4557.
54. Yokote R, Sato M, Matsubara S, Ohye H, Niimi M, Murao K, Takahara J. Molecular cloning and gene expression of growth hormone-releasing peptide receptor in rat tissues. Peptides 1998; 19: 15-20.
55. Whitnall MH. Stress selectively activates the vasopressin-containing subset of corticotrophin-releasing hormone neurons. Neuroendocrinol 1989; 50: 702-707.
56. Donald RA, Alexander SL, Ellis MJ, Evans MJ, Livesey JH, Espiner EA. Regulation of corticotrophin secretion. Clin Sci (Colch) 1995; 88: 4-7.
57. Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts GW, Crow TJ, Tatemoto K, Polak JM. Neuropeptide Y distribution in human brain. Nature 1983; 306: 584-586.
58. Small CJ, Morgan DG, Meeran K, Heath MM, Gunn I, Edwards CM, Gardiner J, Taylor GM, Hurley JD, Rossi M, Goldstone AP, O'Shea D, Smith DM, Ghatei MA, Blum SR. Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proc Natl Acad Sci USA 1997; 94: 11686-11691.